MRUS
Merus N.V. (MRUS)
$
35About Merus N.V. (MRUS)
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
Details
Daily high
$52.16
Daily low
$51.06
Price at open
$52.16
52 Week High
$61.61
52 Week Low
$19.80
Market cap
3.6B
Dividend yield
0.00%
Volume
389,895
Avg. volume
608,217
P/E ratio
-18.18
Merus N.V. News
Details
Daily high
$52.16
Daily low
$51.06
Price at open
$52.16
52 Week High
$61.61
52 Week Low
$19.80
Market cap
3.6B
Dividend yield
0.00%
Volume
389,895
Avg. volume
608,217
P/E ratio
-18.18